Antiviral Peptides as Anti-Influenza Agents.

Agamennone, Mariangela et al.·International journal of molecular sciences·2022·
RPEP-059622022RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Not classified
Evidence
Not graded
Sample
Not reported

What This Study Found

Key Numbers

How They Did This

Why This Research Matters

What This Study Doesn't Tell Us

Trust & Context

Original Title:
Antiviral Peptides as Anti-Influenza Agents.
Published In:
International journal of molecular sciences, 23(19) (2022)
Database ID:
RPEP-05962

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study
What do these levels mean? →

Read More on RethinkPeptides

Related articles coming soon.

Cite This Study

RPEP-05962·https://rethinkpeptides.com/research/RPEP-05962

APA

Agamennone, Mariangela; Fantacuzzi, Marialuigia; Vivenzio, Giovanni; Scala, Maria Carmina; Campiglia, Pietro; Superti, Fabiana; Sala, Marina. (2022). Antiviral Peptides as Anti-Influenza Agents.. International journal of molecular sciences, 23(19). https://doi.org/10.3390/ijms231911433

MLA

Agamennone, Mariangela, et al. "Antiviral Peptides as Anti-Influenza Agents.." International journal of molecular sciences, 2022. https://doi.org/10.3390/ijms231911433

RethinkPeptides

RethinkPeptides Research Database. "Antiviral Peptides as Anti-Influenza Agents." RPEP-05962. Retrieved from https://rethinkpeptides.com/research/agamennone-2022-antiviral-peptides-as-antiinfluenza

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.